■测量重要参数的可穿戴设备可以成为癌症治疗期间在家监测患者的潜在工具。一种类型的可穿戴设备是具有嵌入式传感器的智能T恤。最初,智能T恤旨在帮助运动员进行表现分析。然而,最近,研究人员一直在研究智能T恤作为医疗保健支持工具的使用。总的来说,在癌症治疗期间使用可穿戴设备进行症状监测的知识有限,缺乏共识和对合规性或依从性的认识。
这项研究的目的是评估在2周内接受癌症治疗的青少年和年轻成年患者中使用智能T恤进行家庭生物识别传感器数据监测的依从性和经验。
■这项研究是一项前瞻性研究,单组,混合方法可行性研究。纳入标准为18至39岁的患者和在哥本哈根大学医院接受治疗的患者-Rigshospitalet,丹麦。同意的患者被要求穿Chronolife智能T恤2周。智能T恤有多个传感器和电极,产生了以下六种测量结果:心电图(ECG)测量,胸部呼吸,腹部呼吸,胸阻抗,身体活动(步骤),和皮肤温度。主要终点是依从性,这被定义为每天>8小时的佩戴时间。通过个人调查患者的经历,半结构化电话采访和纸质问卷。
■共纳入10例患者。在研究期间(14d),磨损时间>8小时的天数从0到6(平均2d)不等。Further,3名患者在其数据登记的每一天期间具有>8小时的平均佩戴时间。任何数据登记的天数范围为0至10天(平均6.4天)。访谈的主题分析指出了以下三个主要主题:(1)智能T恤很酷,但不适合癌症患者,(2)该技术限制了智能T恤的使用,(3)数据的监测增加了安全感。问卷的结果表明,患者通常对该设备充满信心。
■虽然未达到主要终点,患者使用智能T恤的经验导致患者认识到需要新技术来改善支持性癌症护理。当被要求穿智能T恤时,患者呈阳性。然而,使用该设备的技术和实践挑战导致依从性低。虽然可穿戴设备可能有家庭监控的潜力,目前的技术在临床应用上还不成熟。
UNASSIGNED: Wearables that measure vital parameters can be potential tools for monitoring patients at home during cancer treatment. One type of wearable is a smart T-shirt with embedded sensors. Initially, smart T-shirts were designed to aid athletes in their performance analyses. Recently however, researchers have been investigating the use of smart T-shirts as supportive tools in health care. In general, the knowledge on the use of wearables for symptom monitoring during cancer treatment is limited, and consensus and awareness about compliance or adherence are lacking.
UNASSIGNED: The aim of this study was to evaluate adherence to and experiences with using a smart T-shirt for the home monitoring of
biometric sensor data among adolescent and young adult patients undergoing cancer treatment during a 2-week period.
UNASSIGNED: This study was a prospective, single-cohort, mixed methods feasibility study. The inclusion criteria were patients aged 18 to 39 years and those who were receiving treatment at Copenhagen University Hospital - Rigshospitalet, Denmark. Consenting patients were asked to wear the Chronolife smart T-shirt for a period of 2 weeks. The smart T-shirt had multiple sensors and electrodes, which engendered the following six measurements: electrocardiogram (ECG) measurements, thoracic respiration, abdominal respiration, thoracic impedance, physical activity (steps), and skin temperature. The primary end point was adherence, which was defined as a wear time of >8 hours per day. The patient experience was investigated via individual, semistructured telephone interviews and a paper questionnaire.
UNASSIGNED: A total of 10 patients were included. The number of days with wear times of >8 hours during the study period (14 d) varied from 0 to 6 (mean 2 d). Further, 3 patients had a mean wear time of >8 hours during each of their days with data registration. The number of days with any data registration ranged from 0 to 10 (mean 6.4 d). The thematic analysis of interviews pointed to the following three main themes: (1) the smart T-shirt is cool but does not fit patients with cancer, (2) the technology limits the use of the smart T-shirt, and (3) the monitoring of data increases the feeling of safety. Results from the questionnaire showed that the patients generally had confidence in the device.
UNASSIGNED: Although the primary end point was not reached, the patients\' experiences with using the smart T-shirt resulted in the knowledge that patients acknowledged the need for new technologies that improve supportive cancer care. The patients were positive when asked to wear the smart T-shirt. However, technical and practical challenges in using the device resulted in low adherence. Although wearables might have potential for home monitoring, the present technology is immature for clinical use.